Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [3]

Thomas Brodowicz; Rainer Kotz; Christoph Wiltschke; Christoph C. Zielinski; Peter Ritschl; C. F. Pollera; Alexander M.M. Eggermont; Schraffordt H. Koops; D. Lienard; B. B.R. Kroon; A. N. Van Geel; H. J. Hoekstra; F. J. Lejeune

doi:10.1200/JCO.1997.15.5.2174

Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [3]

Thomas Brodowicz, Rainer Kotz, Christoph Wiltschke, Christoph C. Zielinski, Peter Ritschl, C. F. Pollera, Alexander M.M. Eggermont, Schraffordt H. Koops, D. Lienard, B. B.R. Kroon, A. N. Van Geel, H. J. Hoekstra, F. J. Lejeune

Research output: Contribution to journal › Letter › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	2174-2175
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	15
Issue number	5
DOIs	https://doi.org/10.1200/JCO.1997.15.5.2174
Publication status	Published - 1997
Externally published	Yes

Access to Document

10.1200/JCO.1997.15.5.2174

Cite this

Brodowicz, T., Kotz, R., Wiltschke, C., Zielinski, C. C., Ritschl, P., Pollera, C. F., Eggermont, A. M. M., Koops, S. H., Lienard, D., Kroon, B. B. R., Van Geel, A. N., Hoekstra, H. J., & Lejeune, F. J. (1997). Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [3]. Journal of Clinical Oncology, 15(5), 2174-2175. https://doi.org/10.1200/JCO.1997.15.5.2174

@article{b2a7e33e77574857a37b9bff3804a289,

title = "Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [3]",

author = "Thomas Brodowicz and Rainer Kotz and Christoph Wiltschke and Zielinski, {Christoph C.} and Peter Ritschl and Pollera, {C. F.} and Eggermont, {Alexander M.M.} and Koops, {Schraffordt H.} and D. Lienard and Kroon, {B. B.R.} and {Van Geel}, {A. N.} and Hoekstra, {H. J.} and Lejeune, {F. J.}",

year = "1997",

doi = "10.1200/JCO.1997.15.5.2174",

language = "English",

volume = "15",

pages = "2174--2175",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

Brodowicz, T, Kotz, R, Wiltschke, C, Zielinski, CC, Ritschl, P, Pollera, CF, Eggermont, AMM, Koops, SH, Lienard, D, Kroon, BBR, Van Geel, AN, Hoekstra, HJ & Lejeune, FJ 1997, 'Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [3]', Journal of Clinical Oncology, vol. 15, no. 5, pp. 2174-2175. https://doi.org/10.1200/JCO.1997.15.5.2174

Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial [3]. / Brodowicz, Thomas; Kotz, Rainer; Wiltschke, Christoph et al.
In: Journal of Clinical Oncology, Vol. 15, No. 5, 1997, p. 2174-2175.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Isolated limb perfusion with high-dose tumor necrosis factor-α in combination with interferon-γ and melphalan for nonresectable extremity soft tissue sarcomas

T2 - A multicenter trial [3]

AU - Brodowicz, Thomas

AU - Kotz, Rainer

AU - Wiltschke, Christoph

AU - Zielinski, Christoph C.

AU - Ritschl, Peter

AU - Pollera, C. F.

AU - Eggermont, Alexander M.M.

AU - Koops, Schraffordt H.

AU - Lienard, D.

AU - Kroon, B. B.R.

AU - Van Geel, A. N.

AU - Hoekstra, H. J.

AU - Lejeune, F. J.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0030903588&partnerID=8YFLogxK

U2 - 10.1200/JCO.1997.15.5.2174

DO - 10.1200/JCO.1997.15.5.2174

M3 - Letter

AN - SCOPUS:0030903588

SN - 0732-183X

VL - 15

SP - 2174

EP - 2175

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 5

ER -